ScholarIQanswers from OpenAlex
Maze Therapeutics
FunderResearch funding and supported work
Maze Therapeutics is a funder indexed in ScholarIQ from OpenAlex.
How many works does Maze Therapeutics have?
ScholarIQindexed works
Maze Therapeutics has 347 works in the ScholarIQ index. The count is the OpenAlex total, not the number of papers listed on this page.
What is the OpenAlex record for Maze Therapeutics?
ScholarIQopenalex
The OpenAlex for Maze Therapeutics is on the source record.
What is the ROR of Maze Therapeutics?
ScholarIQror
The ROR for Maze Therapeutics is on the source record.
What are the most-cited papers on Maze Therapeutics?
ScholarIQmost cited works
KDIGO 2025 clinical practice guideline for the evaluation, management, and treatment of autosomal dominant polycystic kidney disease (ADPKD): executive summary
Vicente E. Torres, Curie Ahn, Thijs R.M. Barten, Godela Brosnahan, Melissa A. Cadnapaphornchai, Arlene B. Chapman, Émilie Cornec-Le Gall, Joost P.H. Drenth, Ron T. Gansevoort, Peter C. Harris, Tess Harris, Shigeo Horie, Max C. Liebau, Michele Liew, Andrew Mallett, Changlin Mei, Djalila Mekahli, Dwight Odland, Albert Ong, Luiz F. Onuchic, York Pei, Ronald D. Perrone, Gopala K. Rangan, Brian Rayner, Roser Torrá, Ethan M. Balk, Craig E. Gordon, Amy Earley, Reem A. Mustafa, Olivier Devuyst